Strategies for the treatment of Alzheimer's disease: The 'ad continuum' concept;Estrategias terapéuticas en la enfermedad de Alzheimer: Concepto ad continuum

Revista de Neurologia

Volumn 32, Issue 11, 2001, Pages 1074-1084

  Boada Rovira, M ^a  

^a Inst Catata de Neurociencies Apl   (Spain)

Author keywords

Dementia; Guidelines and strategies for treatment; Long term treatment; Pharmacological treatment; Symptomatic treatment

Indexed keywords

AMITRIPTYLINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BAY ALPHA 9826; CALCIUM ANTAGONIST; CITALOPRAM; CLOMIPRAMINE; DIHYDROERGOTOXINE MESILATE; DONEPEZIL; FLUOXETINE; FLUVOXAMINE; GALANTAMINE; IMIPRAMINE; LEVOMEPROMAZINE; METRIFONATE; MILAMELINE; MONOAMINE OXIDASE INHIBITOR; NEUROPROTECTIVE AGENT; NICOTINE; NIMODIPINE; NOOTROPIC AGENT; PAROXETINE; PIRACETAM; PROPENTOFYLLINE; RIVASTIGMINE; SABCOMELINE; SEROTONIN UPTAKE INHIBITOR; TACRINE; THIOPILOCARPINE; TRAZODONE; UNINDEXED DRUG;

AFFECTIVE NEUROSIS; ALZHEIMER DISEASE; CONFERENCE PAPER; CONFUSION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEALTH CARE NEED; HUMAN; LONG TERM CARE; PRACTICE GUIDELINE; PSYCHOSIS; SLEEP DISORDER; SOCIAL CARE;

EID: 0034834003     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3211.2000160     Document Type: Conference Paper

References (28)

1. Efficacy and safety results of the early phase studies with EXELONtm (ENA-713) in Alzheimer's disease: An overview
2. Clinical development of EXELONtm (ENA-713): The ADENA programme
3. El tratamiento longitudinal de la enfermedad de Alzheimer
4. Comparative evolution of Alzheimer's disease, vascular dementia, and mixed dementia
5. Fallacies in the pathological conformation of the diagnosis of Alzheimer's disease
6. Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease
7. Metrifonate treatment of the cognitive deficits of Alzheimer's disease
8. Neurobiología y biología molecular de la enfermedad de Alzheimer
9. The effect of different diagnostic criteria on the prevalence of dementia
10. Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon?
11. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and non demented control subjects
12. Effect of tacrine on behavioral symptoms in Alzheimer's disease: An open-label study
13. Dementia with Lewy bodies: Response of delirium-like features to donepezil
14. A 30-week randomized controlled trial of high-dose tactine in patients with Alzheimer's disease
15. Long-term tactine (Cognex) treatment: Effects on nursing home placement and mortality
16. Metrifonate for Alzheimer's disease. Is the next cholinesterase inhibitor better?
17. Rivastigmine in the treatment of dementia with Lewy bodies: Preliminary findings from an open trial
18. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease
19. Estrogen deficiency and risk of Alzheimer's disease in women
20. The efficacy of tacrine in Alzheimer's disease
21. Methodology, results and quality of medical trials of tacrine in the treatment of Alzheimer's disease: A systematic review of the literature
22. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
23. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
24. Terapias blandas: Programa de psicoestimulación integral. Alternativa terapéutica para las personas con enfermedad de Alzheimer
25. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension